Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > We were counted as down and out 8 months ago, we were never

<< Previous

Bullboard Posts

Next >>

Comment by NeedAPoolon Mar 03, 2021 9:46am

90 Views

Post# 32703674

RE:RE:RE:We were counted as down and out 8 months ago, we were never

Your best bet is to start with the press release. It has a lot of information that is presented quite well (for a change...most of these news releases by these companies is full of language that most don't understand.)

https://www.globenewswire.com/news-release/2021/03/02/2185335/0/en/Claritas-Formerly-Kalytera-Therapeutics-Cites-Breakthrough-Data-by-Massachusetts-General-Hospital-and-Others-Demonstrating-the-Effectiveness-of-Nitric-Oxide-as-a-Potential-Therapy-.html

From there go to the company website. Lots of great info. Here is their Overview pagehttps://claritaspharma.com/our-company/overview/

Good luck!

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland